COMMUNIQUÉS West-GlobeNewswire

Solon Eiendom ASA : Primary insider notification

17/07/2017 - 17:40

(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 25,000 shares in Solon Eiendom ASA at a price of NOK 19. Following this [...]

Solon Eiendom ASA : Primary insider notification

17/07/2017 - 17:37

(Oslo, Norway, 17 July 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 80,986 shares in Solon Eiendom ASA at a price of NOK 18,9888. Following [...]

Targovax ASA: Final result of the subsequent offering

17/07/2017 - 15:24

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Five-Year Data Demonstrate InterStim(TM) Therapy Offers Sustained Long-Term Efficacy and Quality of Life Improvements for Overactive Bladder Patients

17/07/2017 - 15:00

The InterStim System is the Only Proven, Long-Term Sacral Neuromodulation Solution for Overactive Active Bladder DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which [...]

RedHill Biopharma Announces Last Patient Visit in BEKINDA® Phase II Study for IBS-D

17/07/2017 - 14:00

Top-line results are expected in September 2017 The randomized, double-blind, placebo-controlled Phase II study is evaluating the safety and efficacy of BEKINDA ® (RHB-102) 12 mg in 127 U.S. patients with diarrhea- [...]

Novo Nordisk A/S - Share repurchase programme

17/07/2017 - 13:56

Bagsværd, Denmark, 17 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

MITHRA SUBMITS MYRING(TM) FOR EUROPEAN MARKETING APPROVAL

17/07/2017 - 07:30

PRESS RELEASE mithra submits MYRING(TM) For EUROpean Marketing approval Myring(TM) regulatory approvals in Europe and the US expected in 2018 Regulatory s ubmission follows recent European GMP approval for Myring(TM) [...]

ABLYNX PROPOSES APPOINTMENT OF MRS HILDE WINDELS AS A NEW INDEPENDENT DIRECTOR

17/07/2017 - 07:00

GHENT, Belgium, 17 July 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced that Hilde Windels will be nominated as an Independent Non-Executive Director at the Company's forthcoming Special General [...]

L'Association internationale pour l'étude du cancer du poumon annonce la 18e Conférence mondiale IASLC sur le cancer du poumon

14/07/2017 - 20:00

La seule conférence mondiale axée uniquement sur le cancer du poumon regroupera des milliers de personnes au Japon DENVER, le 14 juillet 2017 (GLOBE NEWSWIRE) - L'Association internationale pour l'étude du cancer du [...]

Novartis confirms 5 year data for first and only fully-human IL-17A inhibitor Cosentyx® reinforcing sustained efficacy and safety profile in psoriasis

14/07/2017 - 19:21

5 year data from long-term Phase III extension study demonstrate sustained efficacy and safety of Cosentyx in patients with moderate-to-severe plaque psoriasis[1] Data planned to be presented at a key medical congress [...]

IBA SA : IBA - NOTIFICATION DE TRANSPARENCE

14/07/2017 - 17:50

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 14 juillet 2017, 17h40 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]

IBA SA : IBA - TRANSPARENCY NOTIFICATION

14/07/2017 - 17:50

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, July 14, 2017, 5.40 p.m. - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

Targovax ASA: Preliminary result of the subsequent offering

14/07/2017 - 17:24

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Crown Bioscience enrichit son portefeuille de sciences de la vie

14/07/2017 - 12:45

SANTA CLARA, Californie, le 14 juillet 2017 (GLOBE NEWSWIRE) - Crown Bioscience , filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]

Enzymatica recruits Chief Operating Officer

14/07/2017 - 11:30

Press release Lund, 14 July, 2017 Enzymatica recruits Chief Operating Officer Enzymatica has recruited Johan Lindvall as Chief Operating Officer and Executive Vice President. He will be responsible for Enzymatica's [...]

Targovax ASA: Last day of the subscription period in the subsequent offering

14/07/2017 - 07:15

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE [...]

Solon Eiendom ASA : Primary insider notification

13/07/2017 - 23:08

(Oslo, Norway, 13 July 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 25,000 shares in Solon Eiendom ASA at a price of NOK 18,0843. Following this [...]

FOR SALE: State-of-the-Art cGMP-Qualified Solid Dosage Development and Manufacturing Facility

13/07/2017 - 20:52

The 100,000+ sq.-ft. facility is located on Long Island, less than 50 miles from New York City. COMMACK, NY, July 13, 2017 (GLOBE NEWSWIRE) -- A spacious, technologically advanced facility, conveniently located within [...]

GENFIT - The NASH Education ProgramTM annonce le lancement de la première Journée Internationale d'Information sur la NASH, le 12 juin 2018

13/07/2017 - 19:19

GENFIT - The NASH Education Program TM annonce le lancement de la première Journée Internationale d'Information sur la NASH, le 12 juin 2018 Journée internationale de sensibilisation à la NASH, pathologie silencieuse [...]